Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.630
-0.004 (-0.62%)
At close: Dec 20, 2024, 4:00 PM
0.615
-0.015 (-2.38%)
After-hours: Dec 20, 2024, 7:59 PM EST
Cognition Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 22.01 | 29.92 | 41.56 | 54.72 | 5.19 | 2.89 |
Cash & Short-Term Investments | 22.01 | 29.92 | 41.56 | 54.72 | 5.19 | 2.89 |
Cash Growth | -33.24% | -28.01% | -24.05% | 954.56% | 79.55% | - |
Other Receivables | 3.37 | 1.28 | 3.67 | 2.27 | 1.15 | 4.12 |
Receivables | 3.37 | 1.28 | 3.67 | 2.27 | 1.15 | 4.12 |
Prepaid Expenses | 1.45 | 3.02 | 2.41 | 2.01 | 0.54 | 0.12 |
Other Current Assets | - | - | - | - | 0.02 | 0.03 |
Total Current Assets | 26.83 | 34.22 | 47.65 | 58.99 | 6.91 | 7.16 |
Property, Plant & Equipment | 0.75 | 0.94 | 1.05 | 0.15 | 0.21 | 0.3 |
Other Long-Term Assets | - | - | 1.73 | - | - | - |
Accounts Payable | 1.9 | 3.7 | 3.22 | 4.17 | 2 | 2.36 |
Accrued Expenses | 9.51 | 4.06 | 2.09 | 1.75 | 0.99 | 1.32 |
Short-Term Debt | - | 0.54 | 0.63 | - | - | - |
Current Portion of Leases | 0.19 | 0.17 | 0.15 | - | - | 0 |
Current Unearned Revenue | 1.12 | 1.7 | 1.7 | 0.75 | - | - |
Other Current Liabilities | - | - | - | 1.19 | 0.25 | 0 |
Total Current Liabilities | 12.71 | 10.17 | 7.8 | 7.86 | 3.25 | 3.68 |
Long-Term Debt | - | - | - | - | 12.85 | 6.9 |
Long-Term Leases | 0.39 | 0.52 | 0.7 | - | - | - |
Long-Term Unearned Revenue | - | - | 1.69 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | 3.83 | 2.37 |
Common Stock | 0.04 | 0.03 | 0.03 | 0.02 | 0 | 0 |
Additional Paid-In Capital | 181.76 | 165.83 | 155.82 | 145.45 | 0.22 | - |
Retained Earnings | -167.32 | -141.19 | -115.4 | -94 | -68.22 | -58.24 |
Comprehensive Income & Other | - | -0.2 | -0.2 | -0.2 | -0.19 | -0.19 |
Total Common Equity | 14.48 | 24.47 | 40.25 | 51.27 | -68.18 | -58.42 |
Total Liabilities & Equity | 27.58 | 35.16 | 50.43 | 59.14 | 7.12 | 7.46 |
Total Debt | 0.58 | 1.24 | 1.48 | - | 12.85 | 6.9 |
Net Cash (Debt) | 21.43 | 28.68 | 40.08 | 54.72 | -7.66 | -4.01 |
Net Cash Growth | -33.51% | -28.44% | -26.75% | - | - | - |
Net Cash Per Share | 0.59 | 0.96 | 1.70 | 10.54 | -15.08 | -8.54 |
Filing Date Shares Outstanding | 41.55 | 39 | 29.26 | 22.58 | 0.54 | 0.47 |
Total Common Shares Outstanding | 40.81 | 32.17 | 28.99 | 22.23 | 0.54 | 0.47 |
Working Capital | 14.13 | 24.05 | 39.85 | 51.13 | 3.66 | 3.48 |
Book Value Per Share | 0.35 | 0.76 | 1.39 | 2.31 | -126.55 | -124.38 |
Tangible Book Value | 14.48 | 24.47 | 40.25 | 51.27 | -68.18 | -58.42 |
Tangible Book Value Per Share | 0.35 | 0.76 | 1.39 | 2.31 | -126.55 | -124.38 |
Machinery | - | 1.33 | 1.19 | 1.02 | 0.99 | 0.98 |
Source: S&P Capital IQ. Standard template.
Financial Sources.